<noframes id="zd9f3">

    <address id="zd9f3"></address>

    <address id="zd9f3"></address>
    <address id="zd9f3"></address>

    <address id="zd9f3"><nobr id="zd9f3"><meter id="zd9f3"></meter></nobr></address>
    1. Epigenetics
    2. Histone Demethylase

    Histone Demethylase

    There are two classes of enzymes involved in histone methylation: methyltransferases and demethylases. While methyltransferases are responsible for establishing methylation patterns, demethylases are capable of removing methyl groups not only from histones but other proteins as well. Histone demethylases not only target methylated sites on histone tails but also interact with methylated sites on non-histone proteins, such as p53.

    Histone lysine demethylases (KDMs) are of interest as drug targets due to their regulatory roles in chromatin organization and their tight associations with diseases including cancer and mental disorders.

    JMJD1A (also named KDM3A) is a demethylasethat removes methyl from histone lysine H3K9. It plays important roles in various cellular processes, including spermatogenesis, energy metabolism, regulation of stem cell and gender display.

    Jumonji domain-containing 3 (Jmjd3) has been identified as a histone demethylase, which specifically catalyzes the removal of methylation from H3K27me3.

    Histone Demethylase 相关产品 (35):

    Cat. No. Product Name Effect Purity
    • HY-15648B
      GSK-J4 Inhibitor >98.0%
      GSK-J4是一种有效的H3K27me3组蛋白赖氨酸脱甲基酶 (KDM) 抑制剂,抑制 KDM6B和KDM6A的 IC50 分别为8.6 μM 和 6.6 μM。
    • HY-104048
      QC6352 Inhibitor >98.0%
      QC6352 是一种有效的 KDM4C 抑制剂,其 IC50 值为 35 nM。
    • HY-12635
      SP2509 Antagonist 99.24%
      SP2509 是有效,选择性的 LSD1 拮抗剂,IC50 值为 13 nM。
    • HY-18632
      GSK2879552 Inhibitor 99.94%
      GSK2879552 是一种可口服的,不可逆的 LSD1 抑制剂,具有抗肿瘤活性。
    • HY-100421
      CPI-455 Inhibitor >98.0%
      CPI-455 是一种有效的特异性 KDM5 抑制剂。
    • HY-117226A
      GSK 690 Hydrochloride Inhibitor 99.78%
      GSK 690 (Hydrochloride) 是赖氨酸特异性去甲基化酶1 (LSD1) 的可逆抑制剂,Kd 值为 9 nM,IC50 值为 37 nM。
    • HY-102047
      KDOAM-25 Inhibitor
      KDOAM-25是有效,选择性的 KDM5 抑制剂,对KDM5A,KDM5B,KDM5C,KDM5D的 IC50 分别为71,19,69,69 nM。
    • HY-111048
      Corin Inhibitor
      Corin 是组氨酸赖氨酸特异性去甲基化酶 (LSD1) 和组氨酸脱乙酰化酶 (HDAC) 的双重抑制剂,其对 LSD1 的 Ki(inact) 值为 110 nM,对 HDAC1 的 IC50 值为 147 nM。
    • HY-B1496
      Tranylcypromine hemisulfate Inhibitor >99.0%
      Tranylcypromine hemisulfate是一种用于治疗抑郁症的不可逆,非选择性 MAO 抑制剂。
    • HY-101799
      NCGC00244536 Inhibitor 98.57%
      NCGC00244536是高效的 KDM4B 抑制剂,IC50 值为10 nM。
    • HY-12304
      IOX1 Inhibitor
      IOX1是2OG oxygenase高效广谱抑制剂,包括JmjC去甲基化酶家族,对KDM4A和KDM3A的IC50值分别为0.6uM和0.1uM。
    • HY-12782T
      ORY-1001(trans) Inhibitor 99.14%
      ORY-1001 trans 是一种不可逆的选择性赖氨酸特异性脱甲基酶 1A (KDM1A/LSD1) 抑制剂
    • HY-100546A
      GSK-LSD1 Dihydrochloride Inhibitor >98.0%
      GSK-LSD1 Dihydrochloride是有效,选择性,不可逆的赖氨酸特异性脱甲基酶 (LSD1) 抑制剂,IC50 值为16 nM。
    • HY-12725
      ML324 Inhibitor >98.0%
    • HY-13953
      JIB-04 Inhibitor
      JIB-04 是 Jumonji 组蛋白去甲基酶 (Jumonji histone demethylase) 广谱抑制剂,能抑制 JARID1A,JMJD2E,JMJD3,JMJD2A,JMJD2B,JMJD2C 和 JMJD2D 的活性,其 IC50 值分别为 230,340,855,445,435,1100 和 290 nM。
    • HY-15648
      GSK-J1 Inhibitor 99.92%
      GSK-J1 是 H3K27me3/me2-demethylases JMJD3/KDM6BUTX/KDM6A 的抑制剂,对 KDM6B 的 IC50 值为 60 nM。
    • HY-13643
      Daminozide Inhibitor >98.0%
      Daminozide(DMASA; DIMG; B 995)为植物生长调节剂,能选择性抑制KDM2/7 JmjC亚家族。
    • HY-100422
      KDM5-IN-1 Inhibitor >98.0%
      KDM5-IN-1是高效选择,有口服活性的KDM5抑制剂,IC50值为15.1 nM。
    • HY-100744
      AS8351 Inhibitor 99.70%
      AS8351 是一种 KDM5B 抑制剂,可以诱导和维持有活性的染色质标记从而促进心肌细胞样细胞的产生。
    • HY-103713
      Seclidemstat Inhibitor 98.78%
      Seclidemstat (SP-2577) 是一种有效的 LSD1 抑制剂,平均 IC50 值为 127 nM。
    Isoform Specific Products

    Your Search Returned No Results.

    Sorry. There is currently no product that acts on isoform together.

    Please try each isoform separately.